Employment of alternative in vivo cancer models for oncology preclinical investigations
The clinical translation of innovative oncology treatments can be boosted by the establishment of alternative in vivo models based on the chick chorioallantoic membrane. In this project, a biomodel based on commercial cancer cell lines, such as hepatocellular carcinoma, will be established and characterized by standard biological assays. The biomodels will be employed for the efficacy evaluation of novel treatment approaches including hybrid nanomaterials.
Voir la description complète du projetGang Zheng
Università Degli Studi Di Genova
Life Sciences
Biotechnology; Health and Related Sciences & Technology; Nanotechnology
University of Toronto
Globalink Research Award
